{
  "_id": "e9497deb0d2af05d31cc93e22adcd3c721d29a80905dbf9fc843e25ad7ac699d",
  "feed": "wall-street-journal",
  "title": "World News:  Catalent to Expand  J&J Dose Production  ----  By Jared S. Hopkins",
  "text": "<p>   Contract drug manufacturer Catalent Inc. is planning a major expansion of its Covid-19 vaccine production in Europe, enabling it to make more doses of Johnson &amp; Johnson's shot, people familiar with the matter said. </p><p>   Catalent, based in Somerset, N.J., will bring online a second J&amp;J vaccine production line at its plant in Anagni, Italy, during the fourth quarter, the people said. The expansion has the potential to double the plant's output of Covid-19 vaccines, one of the people said. </p><p>   J&amp;J has agreed to provide the EU with 200 million doses this year. The EU has the option of buying another 200 million. </p><p>   Johnson &amp; Johnson declined to comment. The company has enlisted nearly a dozen companies to help produce its Covid-19 shot. </p><p></p>",
  "published": "2021-03-17T06:10:00.000Z",
  "tags": [
    {
      "id": "US4781601046",
      "name": "Johnson & Johnson",
      "offsets": [
        {
          "start": 607,
          "end": 624
        },
        {
          "start": 151,
          "end": 168
        },
        {
          "start": 277,
          "end": 280
        },
        {
          "start": 31,
          "end": 34
        },
        {
          "start": 487,
          "end": 490
        }
      ],
      "nexusId": "10010560"
    }
  ]
}